Patrick Wood
Stock Analyst at Morgan Stanley
(2.90)
# 1,600
Out of 4,868 analysts
89
Total ratings
39.39%
Success rate
2.12%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STE STERIS | Maintains: Equal-Weight | $240 → $260 | $236.23 | +10.06% | 4 | May 19, 2025 | |
| BSX Boston Scientific | Maintains: Overweight | $120 → $125 | $101.37 | +23.31% | 6 | May 16, 2025 | |
| GKOS Glaukos | Maintains: Underweight | $110 → $72 | $102.34 | -29.65% | 4 | May 6, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $86 → $78 | $71.89 | +8.50% | 6 | May 6, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $280 → $196 | $168.59 | +16.26% | 4 | May 6, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $18 → $12 | $11.55 | +3.90% | 7 | May 6, 2025 | |
| TFX Teleflex | Maintains: Overweight | $191 → $173 | $117.72 | +46.96% | 5 | May 5, 2025 | |
| BAX Baxter International | Maintains: Underweight | $30 → $28 | $29.80 | -6.04% | 4 | May 5, 2025 | |
| SOLV Solventum | Maintains: Equal-Weight | $73 → $80 | $72.63 | +10.15% | 4 | Mar 5, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Equal-Weight | $45 → $22 | $20.41 | +7.82% | 4 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $105 → $95 | $59.66 | +59.24% | 2 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $75 → $82 | $81.01 | +1.22% | 7 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $70 → $75 | $73.98 | +1.38% | 8 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $104 → $102 | $69.81 | +46.11% | 5 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $301.79 | +5.04% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $7.87 | +27.06% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $104 → $145 | $124.00 | +16.94% | 1 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $65 → $85 | $84.77 | +0.27% | 3 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $16.85 | +119.58% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $36 | $13.87 | +159.55% | 1 | Dec 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $135.79 | - | 5 | Dec 11, 2017 |
STERIS
May 19, 2025
Maintains: Equal-Weight
Price Target: $240 → $260
Current: $236.23
Upside: +10.06%
Boston Scientific
May 16, 2025
Maintains: Overweight
Price Target: $120 → $125
Current: $101.37
Upside: +23.31%
Glaukos
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $102.34
Upside: -29.65%
GE HealthCare Technologies
May 6, 2025
Maintains: Equal-Weight
Price Target: $86 → $78
Current: $71.89
Upside: +8.50%
Becton, Dickinson and Company
May 6, 2025
Maintains: Overweight
Price Target: $280 → $196
Current: $168.59
Upside: +16.26%
Bausch + Lomb
May 6, 2025
Maintains: Equal-Weight
Price Target: $18 → $12
Current: $11.55
Upside: +3.90%
Teleflex
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $117.72
Upside: +46.96%
Baxter International
May 5, 2025
Maintains: Underweight
Price Target: $30 → $28
Current: $29.80
Upside: -6.04%
Solventum
Mar 5, 2025
Maintains: Equal-Weight
Price Target: $73 → $80
Current: $72.63
Upside: +10.15%
Tandem Diabetes Care
Mar 5, 2025
Downgrades: Equal-Weight
Price Target: $45 → $22
Current: $20.41
Upside: +7.82%
Feb 26, 2025
Maintains: Overweight
Price Target: $105 → $95
Current: $59.66
Upside: +59.24%
Feb 14, 2025
Maintains: Equal-Weight
Price Target: $75 → $82
Current: $81.01
Upside: +1.22%
Feb 12, 2025
Maintains: Equal-Weight
Price Target: $70 → $75
Current: $73.98
Upside: +1.38%
Dec 6, 2024
Maintains: Equal-Weight
Price Target: $104 → $102
Current: $69.81
Upside: +46.11%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $301.79
Upside: +5.04%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $7.87
Upside: +27.06%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $104 → $145
Current: $124.00
Upside: +16.94%
Jul 15, 2024
Upgrades: Equal-Weight
Price Target: $65 → $85
Current: $84.77
Upside: +0.27%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $16.85
Upside: +119.58%
Dec 4, 2023
Initiates: Overweight
Price Target: $36
Current: $13.87
Upside: +159.55%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $135.79
Upside: -